• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢透明细胞癌中 PIK3CA 热点突变和环氧化酶-2 表达:与基质特征密切相关。

PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.

机构信息

Department of Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki, 036-8562 Japan.

Department of Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki, 036-8562 Japan.

出版信息

Hum Pathol. 2019 Apr;86:32-37. doi: 10.1016/j.humpath.2018.11.013. Epub 2018 Nov 26.

DOI:10.1016/j.humpath.2018.11.013
PMID:30496799
Abstract

Ovarian clear cell carcinomas (CCCs) have 2 distinct stromas: a hyalinized/mucoid stroma and a plasma cell-rich inflammatory stroma. Clinically, CCC is the most common ovarian cancer associated with thromboembolism. Recent studies suggested a potential role of PIK3CA mutation in the cyclooxygenase (COX) pathway, which mediates inflammation or hemostasis. In the present study, 54 ovarian CCCs and 3 CCC cell lines were analyzed for PIK3CA hotspot mutation and COX-2 expression with special reference to stromal features. Among the 54 CCCs, 20 (37.0%) and 8 (14.8%) were classified as CCCs with a hyalinized/mucoid stroma and an inflammatory stroma, respectively. PIK3CA mutation was identified in 11 (55%) of the 20 CCCs with a hyalinized/mucoid stroma, but not in any of the 8 CCCs with an inflammatory stroma. In contrast, COX-2 expression was frequent in CCCs with an inflammatory stroma (1/20 [5%] versus 7/8 [87.5%], respectively). Such a relationship between the PIK3CA mutation, COX-2 expression, and stromal features was repeated in the 3 CCC cell lines. Thromboembolism was noted in 9 (16.7%) of the 54 CCC patients, and it was more frequent in CCCs with a hyalinized/mucoid stroma (7/20 [35%]) than in those with an inflammatory stroma (0/8 [0%]). In conclusion, there is a difference in PIK3CA mutation, COX-2 expression, and paraneoplastic thromboembolism between CCCs with a different stroma. It is suggested that a different stromal feature, either hyalinized/mucoid change or inflammation, represents a different molecular genetic background or hemostatic potential in ovarian CCCs.

摘要

卵巢透明细胞癌 (CCC) 有 2 种不同的基质:玻璃样/黏液样基质和富含浆细胞的炎症性基质。临床上,CCC 是最常见的与血栓栓塞相关的卵巢癌。最近的研究表明,PIK3CA 突变在环氧化酶 (COX) 途径中可能发挥作用,该途径介导炎症或止血。在本研究中,分析了 54 例卵巢 CCC 和 3 例 CCC 细胞系的 PIK3CA 热点突变和 COX-2 表达情况,并特别关注了基质特征。在 54 例 CCC 中,20 例(37.0%)和 8 例(14.8%)分别归类为具有玻璃样/黏液样基质和炎症性基质的 CCC。在 20 例具有玻璃样/黏液样基质的 CCC 中,有 11 例(55%)发现 PIK3CA 突变,但在 8 例具有炎症性基质的 CCC 中均未发现。相比之下,具有炎症性基质的 CCC 中 COX-2 表达较为常见(分别为 1/20 [5%]和 7/8 [87.5%])。这种 PIK3CA 突变、COX-2 表达与基质特征之间的关系在 3 例 CCC 细胞系中得到了重复。在 54 例 CCC 患者中,有 9 例(16.7%)发生血栓栓塞,其中具有玻璃样/黏液样基质的 CCC 中更常见(7/20 [35%]),而具有炎症性基质的 CCC 中则罕见(0/8 [0%])。总之,不同基质的 CCC 之间在 PIK3CA 突变、COX-2 表达和副瘤性血栓栓塞方面存在差异。提示卵巢 CCC 中不同的基质特征,无论是玻璃样/黏液样改变还是炎症,代表了不同的分子遗传学背景或止血潜能。

相似文献

1
PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.卵巢透明细胞癌中 PIK3CA 热点突变和环氧化酶-2 表达:与基质特征密切相关。
Hum Pathol. 2019 Apr;86:32-37. doi: 10.1016/j.humpath.2018.11.013. Epub 2018 Nov 26.
2
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.卵巢透明细胞癌中PIK3CA的频繁激活突变。
Am J Pathol. 2009 May;174(5):1597-601. doi: 10.2353/ajpath.2009.081000. Epub 2009 Apr 6.
3
Pathology of clear cell carcinoma of the ovary: A basic view based on cultured cells and modern view from comprehensive approaches.卵巢透明细胞癌的病理学:基于培养细胞的基本观点和综合方法的现代观点。
Pathol Int. 2020 Sep;70(9):591-601. doi: 10.1111/pin.12954. Epub 2020 May 31.
4
Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: manifestation of serial stromal remodeling.卵巢透明细胞癌中交替的黏液样和玻璃样基质:连续基质重塑的表现。
Mod Pathol. 2010 Jun;23(6):881-8. doi: 10.1038/modpathol.2010.75. Epub 2010 Mar 19.
5
Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.骨桥蛋白在卵巢透明细胞癌中的过表达:与肝细胞核因子-1β表达密切相关。
Histopathology. 2008 May;52(6):682-8. doi: 10.1111/j.1365-2559.2008.03006.x. Epub 2008 Apr 2.
6
PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.PIK3CA 突变和 ARID1A 蛋白表达缺失是囊性卵巢透明细胞腺癌发展中的早期事件。
Virchows Arch. 2012 Jan;460(1):77-87. doi: 10.1007/s00428-011-1169-8. Epub 2011 Nov 26.
7
Hyalinized stroma in clear cell carcinoma of the ovary: how is it formed?卵巢透明细胞癌中的玻璃样变基质:它是如何形成的?
Hum Pathol. 2012 Nov;43(11):2041-6. doi: 10.1016/j.humpath.2012.02.012. Epub 2012 May 18.
8
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.整合拷贝数与表达分析可识别卵巢透明细胞癌中全臂染色体改变的特征及预后良好的亚组。
PLoS One. 2015 Jun 4;10(6):e0128066. doi: 10.1371/journal.pone.0128066. eCollection 2015.
9
DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.亲和纯化卵巢透明细胞癌的 DNA 拷贝数谱。
Clin Cancer Res. 2010 Apr 1;16(7):1997-2008. doi: 10.1158/1078-0432.CCR-09-2105. Epub 2010 Mar 16.
10
Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma.卵巢透明细胞癌患者在位子宫内膜中频繁出现 PIK3CA 突变。
Mod Pathol. 2021 Nov;34(11):2071-2079. doi: 10.1038/s41379-021-00861-3. Epub 2021 Jun 25.

引用本文的文献

1
The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Ovarian Cancer: New Insight and Future Perspectives.中性粒细胞胞外诱捕网(NETs)在卵巢癌发病机制中的作用:新见解与未来展望
Mol Biotechnol. 2025 Jul 12. doi: 10.1007/s12033-025-01473-x.
2
Clinicopathological factors of ovarian clear cell carcinoma: A single institutional analysis of 247 cases in China.卵巢透明细胞癌的临床病理因素:中国247例单中心分析
Biomol Biomed. 2025 Jan 14;25(2):436-444. doi: 10.17305/bb.2024.10958.
3
Status and development of research on clear cell carcinoma of the ovary-a visualization-based bibliometric analysis.
卵巢透明细胞癌的研究现状与进展——基于可视化的文献计量分析
Transl Cancer Res. 2024 Jun 30;13(6):2950-2970. doi: 10.21037/tcr-23-2351. Epub 2024 Jun 27.
4
Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics.从基因组学和表观基因组学的角度回顾卵巢透明细胞癌的进展。
Front Genet. 2023 Feb 16;14:952379. doi: 10.3389/fgene.2023.952379. eCollection 2023.
5
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues.下一代测序技术展示了卵巢透明细胞癌的基因组特征,并比较了卵巢和子宫内膜组织中高级别浆液性卵巢癌和透明细胞癌的遗传结构。
PeerJ. 2023 Jan 26;11:e14653. doi: 10.7717/peerj.14653. eCollection 2023.
6
Exploring the Anti-inflammatory Effects of Protopine Total Alkaloids of (Willd.) R. Br.探索(威氏)R. Br. 原阿片碱总生物碱的抗炎作用
Front Vet Sci. 2022 Jul 5;9:935201. doi: 10.3389/fvets.2022.935201. eCollection 2022.
7
Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.子宫内膜异位症相关卵巢癌:起源与靶向治疗
Cancers (Basel). 2020 Jun 24;12(6):1676. doi: 10.3390/cancers12061676.